Περίληψη:
BackgroundHearing and vision impairments are highly prevalent in people
with dementia and may have a negative impact on quality of life and
other dementia-related outcomes. Intervening to optimise sensory
impairment and support sensory function may be a means of improving
dementia-related outcomes. The SENSE-Cog trial will test whether a
home-based multi-part sensory intervention is effective in improving
quality of life and other key outcomes in people with dementia and
hearing or vision problems (or both) and their companions.MethodsThis is
anEuropean, multi-centre, observer-blind, pragmatic, randomised
controlled trial. Three hundred fifty four people with dementia and
hearing or vision impairment (or both) and their companions will be
randomly assigned to receive either care as usual or a multi-component
sensory intervention including assessment and correction of hearing or
vision impairments (or both), home-based (maximum 10 visits over
18weeks), therapist-delivered sensory support (that is, adherence to
devices; improving the sensory environment (that is, lighting),
communication training, and sign-posting to other support agencies).
Change from baseline to intervention end (18weeks) and post-intervention
(36weeks) will be compared between the two arms in the following
outcomes: quality of life (primary endpoint), sensory and cognitive
functional ability, relationships, mental well-being, health resource
utilisation and cost-effectiveness.DiscussionThis is one of two articles
outlining the SENSE-Cog trial. Here, we describe the protocol for the
effectiveness of the SENSE-Cog intervention. A parallel and
complementary process evaluation will be described elsewhere. If the
SENSE-Cog trial demonstrates that the sensory intervention improves
outcomes in dementia, we will make a toolkit of training materials,
resources and information available to health and social care providers
to implement the intervention in routine practice. This will be a
significant contribution to the therapeutic management of people with
dementia and sensory impairment.Trial registrationISRCTN (Trial ID:
ISRCTN17056211) on 19 February 2018.
Συγγραφείς:
Regan, Jemma
Frison, Eric
Collin, Fideline
Dawes, Piers and
Hann, Mark
Himmelsbach, Ines
Hooper, Emma
Reeves, David and
Simkin, Zoe
Thodi, Chryssoula
Yang, Fan
Leroi, Iracema and
Abrams, Harvey
Chaghil-Boissiere, Nathalie
Charalambous, Pavlina
and Constantinidou, Fofi
Gilbert, Camille
Helmer, Catherine and
Jury, Francine
Kontogianni, Evangelia
Lawlor, Brian
Matard,
Charly
Montecelo, Susana
Marie, Sarah
Politis, Antonios and
Postea, Otilia
Renaud, David
Termote, Monique
Wolski, Lucas
and SENSE-Cog Trial Dev Team
